ES2177625T3 - Citoquina cc-1 humana circulante. - Google Patents

Citoquina cc-1 humana circulante.

Info

Publication number
ES2177625T3
ES2177625T3 ES95905105T ES95905105T ES2177625T3 ES 2177625 T3 ES2177625 T3 ES 2177625T3 ES 95905105 T ES95905105 T ES 95905105T ES 95905105 T ES95905105 T ES 95905105T ES 2177625 T3 ES2177625 T3 ES 2177625T3
Authority
ES
Spain
Prior art keywords
cytoquine
circulating human
derivatives
circulating
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95905105T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Peter Schulz-Knappe
Markus Meyer
Hans-Jurgen Magert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934344397 external-priority patent/DE4344397A1/de
Priority claimed from DE19944427395 external-priority patent/DE4427395A1/de
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2177625T3 publication Critical patent/ES2177625T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Radar Systems Or Details Thereof (AREA)

Abstract

CITOQUINA CC-1 CON LA SIGUIENTE SECUENCIA DE AMINOACIDOS SEGUN SEC. ID N OGICAMENTE ACTIVOS, ESPECIALMENTE AMIDADOS, ACETILADOS, FOSFORILADOS Y/O GLICOSILADOS.
ES95905105T 1993-12-24 1994-12-22 Citoquina cc-1 humana circulante. Expired - Lifetime ES2177625T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19934344397 DE4344397A1 (de) 1993-12-24 1993-12-24 Humanes zirkulierendes Cytokin CC-1
DE19944427395 DE4427395A1 (de) 1994-08-03 1994-08-03 Humanes zirkulierendes Cytokin CC-1

Publications (1)

Publication Number Publication Date
ES2177625T3 true ES2177625T3 (es) 2002-12-16

Family

ID=25932491

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95905105T Expired - Lifetime ES2177625T3 (es) 1993-12-24 1994-12-22 Citoquina cc-1 humana circulante.

Country Status (9)

Country Link
US (3) US20030105293A1 (es)
EP (1) EP0736095B1 (es)
JP (1) JP3630685B2 (es)
AT (1) ATE218616T1 (es)
AU (1) AU680714B2 (es)
CA (1) CA2179638A1 (es)
DE (1) DE59410132D1 (es)
ES (1) ES2177625T3 (es)
WO (1) WO1995018228A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6623942B2 (en) 1994-03-08 2003-09-23 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polynucleotides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US5602008A (en) * 1994-11-29 1997-02-11 Incyte Pharmaceuticals, Inc. DNA encoding a liver expressed chemokine
KR19990008335A (ko) * 1995-05-05 1999-01-25 로버트 에리치. 벤슨 인체 케모킨 베타-8, 케모킨 베타-1 및 대식세포 염증 단백질-4
US6713052B1 (en) 1995-10-24 2004-03-30 Human Genome Sciences, Inc. Method of mobilizing stem cells with chemokine β-8
ZA968897B (en) * 1995-10-24 1998-07-14 Smithkline Beecham Corp Novel chemokine for mobilizing stem cells
EP1422239A3 (en) * 1995-10-24 2004-12-01 Smithkline Beecham Corporation Mobilization of hematopoietic stem cells using a chemokine
DE59712567D1 (en) * 1996-04-30 2006-04-13 Pharis Biotec Gmbh Chemokine vom cc-typ
WO1998014582A1 (en) * 1996-09-30 1998-04-09 Human Genome Sciences, Inc. Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)
DE60030749T2 (de) * 1999-10-25 2007-09-20 Pharis Biotec Gmbh Prozessiertes menschliches chemokin phc-1
EP1167527A1 (en) * 2000-06-22 2002-01-02 Euroscreen S.A. Processed human chemokines PHC-1 and PHC-2
AU2004283853A1 (en) * 2003-10-24 2005-05-06 Tap Pharmaceutical Products Inc. Human chemokine HCC-1 polypeptides to improve stem cell transplantation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
WO1993013206A1 (en) * 1991-12-23 1993-07-08 British Bio-Technology Limited Stem cell inhibiting proteins

Also Published As

Publication number Publication date
JPH09510084A (ja) 1997-10-14
CA2179638A1 (en) 1995-07-06
US20080234187A1 (en) 2008-09-25
US20050106678A1 (en) 2005-05-19
AU1384995A (en) 1995-07-17
JP3630685B2 (ja) 2005-03-16
EP0736095A1 (de) 1996-10-09
ATE218616T1 (de) 2002-06-15
WO1995018228A1 (de) 1995-07-06
AU680714B2 (en) 1997-08-07
US20030105293A1 (en) 2003-06-05
DE59410132D1 (de) 2002-07-11
EP0736095B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
ATE188486T1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
ES2177625T3 (es) Citoquina cc-1 humana circulante.
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
TR199901754T2 (xx) Helicobacter pylori enfeksiyonlar�n�n ve bunlarla ba�lant�l� gastro-duodenal rahats�zl�klar�n tedavisinde
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
IS5027A (is) Lífvirk peptíð, not fyrir þau og vinnsla þeirra
DK0759775T3 (da) Flydende IFN-beta-formuleringer
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
IL91184A0 (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
EP0273800A3 (en) Hirudine variants, their use and preparation
NZ230654A (en) Anti-cell proliferative penta and hexa peptides
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
EP0919621A4 (en) HUMAN TAK1 AND DNA CODING THEM
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DE69736325D1 (de) Cr1 fragmente und deren verwendung
IT1235442B (it) Procedimento ed impianto per la disinfezione di impianti idrosanitari in particolare per idromassaggio
GB9723824D0 (en) Cytostatic agents
RU96103721A (ru) Антгельминтное средство
FI933386A7 (fi) Pienimolekyylisiä sulfatoituja poly-b-2,6-fruktofuranosaaneja ja niide n käyttö rappeuttavien nivelsairauksien hoitoon